Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Nephro Care India IPO
Price Band
₹85.0–90.0
Issue Size
₹41.26 Cr
Lot Size
1,600 shares
Min Investment
₹144,000
GMP
+₹175.0 (194.44%)
Issue Price
₹90.0
Subject to Sauda
₹212800
Paid only if allotted
Nephro Care India IPO AI Summary
- Nephro Care India IPO is listed on NSE SME in the Hospital sector.
- Price band: ₹85.0–₹90.0 per share, lot size 1,600 shares (min. investment ₹144,000).
- Subscription window: 28 Jun–02 Jul 2024, listing on 05 Jul 2024.
- Current GMP is +₹175.0 (194.44%), an estimated listing price of ₹265 — unofficial and can change daily.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Nephro Care India IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 02 Jul 2024 — not a current signal.
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Nephro Care India IPO Grey Market Premium (GMP) Today
GMP
+₹175.0
GMP %
+194.44%
Est. Listing
₹265.0
Updated: 25 Jul 2026 14:05
About the Company
Incorporated in 2014, Nephro Care India Limited is a comprehensive treatment center located in Kolkata, offering a wide range of clinical and lifestyle solutions, as well as renal insufficiency treatment for patients. Nephro Care is supported by expert doctors, experienced paramedical professionals, and a skilled management team. Currently, the hospital provides healthcare services to approximately 900 Chronic Kidney Disease patients every month. The hospital has 5 permanent doctors, 10 visiting consultants, and 70 experienced paramedical professionals. These services are delivered from its main Salt Lake clinic, which covers an area of 5,352 square feet, and three satellite clinics located in Salt Lake (HB 113) and Chandannagar, West Bengal. At present, Nephro Care offers the following services at its clinics: In-house Dialysis Unit Outpatient Services in areas of Nephrology, Diabetology, Cardiology, Ophthalmology and Neurology NABL accredited inhouse Pathology Inhouse Pharmacy Advance diagnostic facilities Renal Nutrition department Home Care Mukti (Lifestyle Support Program) Home Dialysis As of March 31, 2024 the hospital employs 110 people in various departments.
Company Financials (₹ Cr)
As of 2023-12-31
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 20.30 | 8.31 | 4.63 | 1.13 |
| Total Income | 19.90 | 17.10 | 3.43 | 1.83 |
| Profit After Tax | 3.40 | 1.94 | -0.01 | 0.09 |
| NET Worth | 13.92 | 2.44 | 0.50 | 0.02 |
| Reserves and Surplus | 13.33 | 1.94 | -0.00 | 0.01 |
| Total Borrowing | 2.46 | 2.54 | 0.69 |
Key Ratios
EPS
₹1.63
NAV
₹11.20
ROE
41.57%
ROCE
36.56%
RoNW
24.42%
P/B Value
8.04
P/E Ratio
55.15
Market Cap
₹148.38 Cr
PAT Margin
17.22%
Peer Comparison
| Company | NAV | RoNW | P/E (x) | EPS Basic | EPS Diluted |
|---|---|---|---|---|---|
| Nephro Care India Limited This IPO | 2.44 | 79.68% | 55.15 | 1.94 | 1.94 |
Promoters
Pratim Sengupta
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Setting up a Multi Speciality Hospital in the name of “Vivacity Multi Specialty Hospital” (unit of Nephro Care) at Kolkata (Madhyamgaram), West Bengal 26.15 2 General Corporate Expenses 10.03
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total income was ₹3.43 Cr in 31 Mar 2022, rising to ₹17.10 Cr by 31 Mar 2023, and further increasing to ₹19.90 Cr by 31 Dec 2023. This growth indicates a strong upward trend in revenue over the observed periods.
Profit Trend
Profit after tax was a loss of ₹0.01 Cr in 31 Mar 2022, which improved to ₹1.94 Cr by 31 Mar 2023, and further rose to ₹3.40 Cr by 31 Dec 2023. This shows a significant recovery and growth in profitability over the periods.
Valuation
At the issue price of ₹90, Nephro Care India Limited has an implied P/E ratio of approximately 55.15 based on its earnings per share (EPS) of ₹1.63. This is in line with its peer group's P/E ratio of 55.15.
Grey Market Premium, Explained
The Grey Market Premium (GMP) indicates the expected premium at which the shares are likely to list on the stock exchange compared to the issue price. A high GMP suggests strong demand for the shares in the grey market, which may translate to listing gains.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their financial goals and risk tolerance. It's important to consider the company's growth potential and market conditions before making a decision.
Who May Want to Wait
Investors who prefer stable, established companies with a long track record may want to avoid this IPO, as it involves higher risk associated with new and growing businesses.
Listing Gains — The Risk
Listing-day gains can be unpredictable and are influenced by various factors, including market conditions and investor sentiment. While a strong GMP may suggest potential gains, there is always a risk that the shares may not perform as expected on the listing day.
This evaluation is generated from Nephro Care India's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Nephro Care India IPO GMP today?
Nephro Care India IPO GMP today is +₹175.0 (194.44%), indicating an estimated listing price of ₹265. GMP is an unofficial grey-market indicator and can change daily.
What is the price band of Nephro Care India IPO?
The price band of Nephro Care India IPO is ₹85.0–₹90.0 per share.
When does Nephro Care India IPO open and close?
Nephro Care India IPO opens on 28 June 2024 and closes on 02 July 2024.
When does Nephro Care India IPO list on the stock exchange?
Nephro Care India IPO listed on 05 July 2024 at ₹265.0.
What is the lot size for Nephro Care India IPO?
The lot size for Nephro Care India IPO is 1600 shares, requiring a minimum investment of ₹144,000.
What is the lot size for this IPO?
The lot size for Nephro Care India Limited's IPO is 1600 shares.
What is the minimum investment required?
The minimum investment required is ₹144,000.
What is the price band for the IPO?
The price band for the IPO is ₹85.00 to ₹90.00.
When does the IPO open and close?
The IPO opens on June 28, 2024, and closes on July 2, 2024.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected premium at which the shares may list compared to the issue price.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
28 Jun 2024
Close
02 Jul 2024
Allotment
03 Jul 2024
Listing
05 Jul 2024
Similar IPOs in Hospital
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Nephro Care India?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.